Sana Biotechnology Inc (NASDAQ:SANA) currently has a daily average trading volume of 7.05M but it saw 1286161 shares traded in last market. With a market cap of 683.20M USD, the company’s current market price of $3.06 came falling about -0.97 while comparing to the previous closing price of $3.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.00 and as low as $1.52.
Taking a look at 20-day trading activity of Sana Biotechnology Inc (SANA) gives us an average price of $3.14, while its current price level is -74.50% below from 52-week high level whereas it is 101.32% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.68 while that of 200 days or SMA-200 reads an average of $4.60. A closer look into the stock’s movement over the week reveals that its volatility is standing at 7.74% during that period while stretching the period over a month that increases to 10.34%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 51.34 which implies that the stock is in neutral territory.
Rodman & Renshaw issued its recommendations for the stock as it initiated the price target for the stock is $16.
Over the week, SANA’s stock price is moving 7.75% up while it is 4.79% when we observe its performance for the past one month. Year-to-date it is 87.73% up and over the past year, the stock is showing a downside performance of -64.75%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.26 while estimate for next year EPS is -1.14.
Currently, Sana Biotechnology Inc’s total number of outstanding shares is 223.11M with 8.64% of that held by the insiders while 94.47% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -80.91% and return on equity (ROE) at -92.90%. Stock’s beta reads 1.60. Stock has a price to book (P/B) ratio of 2.33. Its return on asset (ROA) is -51.36% on average.
